Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1.
J Med Econ. 2023 Jan-Dec;26(1):445-453. doi: 10.1080/13696998.2023.2188844.
J Med Econ. 2023.
PMID: 36883193
Free article.
Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers.
Arriola E, Bernabé R, Campelo RG, Biscuola M, Enguita AB, López-Ríos F, Martínez R, Mezquita L, Palanca S, Pareja MJ, Zugazagoitia J, Arrabal N, García JF, Carcedo D, de Álava E.
Arriola E, et al. Among authors: arrabal n.
JCO Precis Oncol. 2023 Mar;7:e2200546. doi: 10.1200/PO.22.00546.
JCO Precis Oncol. 2023.
PMID: 36862967
Free PMC article.
Item in Clipboard
Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain.
De Castro J, Insa A, Collado-Borrell R, Escudero-Vilaplana V, Martínez A, Fernandez E, Sullivan I, Arrabal N, Carcedo D, Manzaneque A.
De Castro J, et al. Among authors: arrabal n.
BMC Pulm Med. 2023 Feb 21;23(1):69. doi: 10.1186/s12890-023-02356-0.
BMC Pulm Med. 2023.
PMID: 36809990
Free PMC article.
Item in Clipboard
Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain.
Isla D, Lopez-Brea M, Espinosa M, Arrabal N, Pérez-Parente D, Carcedo D, Bernabé-Caro R.
Isla D, et al. Among authors: arrabal n.
Cost Eff Resour Alloc. 2023 Jan 16;21(1):6. doi: 10.1186/s12962-023-00417-z.
Cost Eff Resour Alloc. 2023.
PMID: 36647072
Free PMC article.
Item in Clipboard
Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective.
de Alava E, Pareja MJ, Carcedo D, Arrabal N, García JF, Bernabé-Caro R.
de Alava E, et al. Among authors: arrabal n.
Expert Rev Pharmacoecon Outcomes Res. 2022 Sep;22(6):1033-1042. doi: 10.1080/14737167.2022.2078310. Epub 2022 May 25.
Expert Rev Pharmacoecon Outcomes Res. 2022.
PMID: 35593180
Free article.
Item in Clipboard
Clinical and economic impact of 'ROS1-testing' strategy compared to a 'no-ROS1-testing' strategy in advanced NSCLC in Spain.
Rojo F, Conde E, Torres H, Cabezón-Gutiérrez L, Bautista D, Ramos I, Carcedo D, Arrabal N, García JF, Galán R, Nadal E.
Rojo F, et al. Among authors: arrabal n.
BMC Cancer. 2022 Mar 19;22(1):292. doi: 10.1186/s12885-022-09397-4.
BMC Cancer. 2022.
PMID: 35303812
Free PMC article.
Item in Clipboard
[The evolution of quality care indicators of patients with type 2 diabetes in the Spanish primary care (1996-2007). The RedGEDAPS quality of care program].
Franch Nadal J, Artola Menéndez S, Diez Espino J, Mata Cases M; en representación de la Red de Grupos de Estudio de la Diabetes en Atención Primaria de la Salud.
Franch Nadal J, et al.
Med Clin (Barc). 2010 Nov 6;135(13):600-7. doi: 10.1016/j.medcli.2009.06.033. Epub 2009 Sep 18.
Med Clin (Barc). 2010.
PMID: 19765772
Spanish.
No abstract available.
Item in Clipboard
Cite
Cite